Figure 1.
Cumulative incidence of grade 3+ infections while on study drug (tranexamic acid [TXA] or placebo). Outcomes of patients were censored when discontinuing the study drug; death was treated as a competing risk.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.